Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.

Regency Centers Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK – Research Report) and Regeneron ...

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Regeneron (REGN)

UBS analyst Chen Chen maintained a Hold rating on RemeGen Co. Ltd. Class H on December 9 and set a price target of HK$63.80. The company’s shares c...

RemeGen Co. Ltd. Class H (9995) Gets a Hold from UBS

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron, with a price target of $850.00. According to TipR...

Regeneron (REGN) Receives a Buy from BMO Capital

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Regeneron yesterday and set a price target of $745.00. According to TipRanks, Bansal i...

Wells Fargo Keeps Their Hold Rating on Regeneron (REGN)

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Regeneron, with a price target of $708.00. According to Tip...

RBC Capital Sticks to Its Hold Rating for Regeneron (REGN)

The latest update is out from Regency Centers ( ($REG) ). On December 8, 2025, Regency Centers Corporation released an updated investor presentatio...

Regency Centers Releases Updated Investor Presentation

Regency Centers ( ($REG) ) has shared an announcement. On December 8, 2025, Regency Centers Corporation released an updated investor presentation f...

In a report released today, Todd Thomas from KeyBanc downgraded Regency Centers to a Hold, with a price target of $84.00. Thomas covers the Real Es...

Regency Centers (REG) was downgraded to a Hold Rating at KeyBanc

Regis Healthcare Ltd. ( ($AU:REG) ) has issued an announcement. Regis Healthcare Ltd announced a change in the director’s interest, with Linda Jane...

Regis Healthcare Announces Director’s Interest Change

The latest announcement is out from Regis Healthcare Ltd. ( ($AU:REG) ). Regis Healthcare Ltd. has announced the issuance of 305,330 performance ri...

Regis Healthcare Issues Performance Rights to Employees

Citic Securities analyst maintained a Buy rating on RemeGen Co. Ltd. Class H on December 1 and set a price target of HK$97.00. The company’s shares...

Citic Securities Remains a Buy on RemeGen Co. Ltd. Class H (9995)

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Regency Centers (REG – Research Report) and Goodman...

Analysts Offer Insights on Real Estate Companies: Regency Centers (REG) and Goodman Group (OtherGMGSF)

The Invesco QQQ ETF ($QQQ) rose 0.81% on Friday, with major indices ending the last trading session of November on a positive note. However, Novemb...

QQQ ETF Daily Update, 12/1/2025

Analysts are intrested in these 5 stocks: ( ($EXAS) ), ( ($REGN) ), ( ($MRVL) ), ( ($FROG) ) and ( ($JAZZ) ). Here is a breakdown of their recent


Exact Sciences, Regeneron, Marvell, JFrog, Jazz: Trending by Analysts

The Invesco QQQ ETF ($QQQ) rose 0.88% on Wednesday as major averages closed higher for the fourth straight day, ahead of the Thanksgiving holiday. ...

QQQ ETF News, 11/27/2025

Creactives Group S.p.A. ( ($IT:CREG) ) has shared an announcement. Creactives Group S.p.A. has announced the approval of implementing regulations f...

Creactives Group Approves New Stock Option Plan

Scotiabank analyst Louise Chen maintained a Hold rating on Regeneron today and set a price target of $770.00. Chen covers the Healthcare sector, fo...

Scotiabank Reaffirms Their Hold Rating on Regeneron (REGN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Gilead Sciences ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

An announcement from Regis Healthcare Ltd. ( ($AU:REG) ) is now available. Regis Healthcare Limited announced the results of its Annual General Mee...

Regis Healthcare Successfully Concludes Annual General Meeting with Key Resolutions Passed

Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio...

Market Cap	$13.12B	P/E Ratio	14.63
52W High	$78.18	52W Low	$63.44
Div Yield	302.0%	Payout Ratio	497.4%
EPS Growth 3Y	0.0%	52W Position	29.3%
Overall Score	64	Value Score	90
Quality Score	57	Technical Score	45

EPS Current Est	$4.63	EPS Next Est	$4.8
EPS Growth Est	+3.7%	DPS Growth 3Y	2.9%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	REG	$67.76	0.00%	1.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	REG	$67.76	0%	1.02M
3
4
5
6

REG

REG

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Regency Centers Corporation Data in Excel

Get Regency Centers Corporation Data in Excel